Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Lucie Viktoria Knight has worked on the following 8 EPO patent applications which have been published in the last five years:

EP12724950

IMMUNOGENIC COMPOSITION

IPC classification:
A61K 39/08, C07K 14/33, C12N 15/62
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Lucie Viktoria Knight, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP13801540

IMMUNOGENIC COMPOSITION

IPC classification:
A61K 39/08, C07K 14/33
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Lucie Viktoria Knight, GlaxoSmithKline
Status:
GRANT OF PATENT INTENDED
EP13817931

IMMUNOGENIC COMPOSITION COMPRISING ELEMENTS OF C. DIFFICILE CDTB AND/OR CDTA PROTEINS

IPC classification:
A61K 39/08
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Lucie Viktoria Knight, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP14700370

MODIFIED ACE2 POLYPEPTIDES

IPC classification:
A61K 38/48, C12N 9/48
Applicant:
Apeiron Biologics AG
Agent:
Lucie Viktoria Knight, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP15704798

MICROBIOLOGICAL PROCESS

IPC classification:
A61K 31/445, C12P 17/12, C12R 1/465
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Lucie Viktoria Knight, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP15824385

COMPOUNDS

IPC classification:
A61K 31/519, A61P 25/28, C07D 471/14
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Lucie Viktoria Knight, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP15762763

TRICYCLIC NITROGEN CONTAINING COMPOUNDS FOR TREATING NEISSERIA GONORRHOEA INFECTION

IPC classification:
A61K 31/4375, A61K 31/4985, A61K 31/538, A61K 31/5383, A61K 31/5415, A61K 31/542, A61K 31/554, A61P 31/04
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Lucie Viktoria Knight, GlaxoSmithKline
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature